Sort
82,697 grants matching “vaccine development”
Novel Adjuvants/Delivery Systems for Biodefense Vaccines
$1,624,853Novartis Vaccines And Diagnostics, Inc. · U01 · FY2005 · AI
Southern California Primary Infection Program
$1,624,645University Of California San Diego · U01 · FY2002 · AI
Eliciting B cells to produce anti-HIV gp41 MPER-specific neutralizing antibodies
$1,624,603Ellis L Reinherz · Dana-Farber Cancer Inst · U19 · FY2011 · AI
HIV-1 Vaccines Designed to Induce Mucosal Immunity
$1,624,512University Of California Davis · U19 · FY2002 · AI
Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy
$1,624,315Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
DEVELOPMENT OF VACCINES FOR INFLUENZA USING AN IMMUNO-MODULATOR ADJUVANT AND MULTI-PLATFORM APPROACH
$1,624,291Bruxanne El-Kammash · University Of Chicago · N01 · FY2025 · AI
Protein-mediated membrane remodeling
$1,623,802Leonid V. Chernomordik · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2016 · HD
Exploring mechanisms that govern immune homeostasis in skin
$1,623,479Keisuke Nagao · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Laboratory Studies of Human Respiratory Syncytial Virus and Other Pneumoviruses
$1,623,430Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Immune Response Consortium: Integrated In Silico, In Vitro, and In Vivo Studies
$1,622,994Arup K. Chakraborty · Massachusetts Institute Of Technology · P01 · FY2009 · AI
Cancer Biomaterials Engineering
$1,622,958Matthew Wolf · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
NOVEL IMMUNE BASED THERAPIES FOR MULTIPLE MYELOMA
$1,622,897Dana-Farber Cancer Institute · P01 · FY2000 · CA
Development of a Chimeric Syphilis Vaccine Candidate to Combat Local, Disseminated and Congenital Syphilis Infection
$1,622,474Caroline E Cameron · University Of Victoria · U01 · FY2024 · AI
Laboratory And Preclinical Studies Of Flaviviruses
$1,621,584Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
CPRC Resources
$1,621,521Melween I. Martinez · University Of Puerto Rico Med Sciences · P40 · FY2021 · OD
ETIB Clinical Research Core
$1,620,926Ronald Gress · Division Of Basic Sciences - Nci · ZID · FY2014 · CA
The molecular pathogenesis of varicella zoster virus infection
$1,620,840Donald Gilden · University Of Colorado Denver · P01 · FY2010 · AG
Novel Heterologous Adenovirus Prime-Boost HIV-1 Vaccine
$1,620,774Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2009 · AI
Immune Reconstitution
$1,619,845Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Production of New Adenovector Constructs with Fiber-Shaft Modifications
$1,619,454Kimberly Wallace · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
cGMP Manufacture, Fill-Finish, Release, and Stability Testing of a Nanoparticle Based HIV Envelope Containing Vaccine
$1,619,441Timothy Fouts · Advanced Bioscience Laboratories, Inc. · N01 · FY2023 · AI
CANCER CHEMOTHERAPY PROGRAM PROJECT
$1,618,980Sloan-Kettering Institute For Cancer Res · P01 · FY2004 · CA
Evolution & Maintenance of Memory CD8 T Cells
$1,618,887Katherine F Luzuriaga · Univ Of Massachusetts Med Sch Worcester · P01 · FY2008 · AI
VACCINE INDUCED IMMUNITY IN THE YOUNG AND AGED
$1,618,735Emory University · U19 · FY2003 · AI
Vaccine Studies Of Simian Immunodeficiency Virus (SIV) in Macaques
$1,618,372Vanessa M. Hirsch · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI